Previous studies have suggested that LFA-3 has an important role in a number of chronic inflammatory pathologies, although an active role for LFA-3 within in vivo inflammatory reactions has not previously been directly observed in humans. To assess the importance of LFA-3 in this process, this study used an adaptation of the Stamper-Woodruff lymphocyte adhesion assay to measure the binding of exogenous activated lymphocytes to the T-cell- dominated chronic inflammatory infiltrate of oral lichen planus. Antibody blockade experiments showed that anti-LFA-3 monoclonal antibody reduced lymphocyte adhesion by ≃ 29%, while anti-ICAM-1 produced a reduction of 26%. These results thus suggest that both LFA-3 and ICAM-1 are likely to mediate cell-cell interactions within lesional tissues in vivo. Moreover, these findings are also the first to directly demonstrate that LFA-3-mediated adhesion, like that of ICAM-1, is functionally important in the molecular pathology of inflammatory mucosal disease.
CITATION STYLE
Kirby, A. C., Cahen, P., Porter, S. R., & Olsen, I. (1999). LFA-3 (CD58) mediates T-lymphocyte adhesion in chronic inflammatory infiltrates. Scandinavian Journal of Immunology, 50(5), 469–474. https://doi.org/10.1046/j.1365-3083.1999.00615.x
Mendeley helps you to discover research relevant for your work.